Goldman Sachs quarterly bond trading revenue drops 26 percent
October 17, 2017
Wall St flat as losses in financials offset healthcare gains
October 17, 2017

Strong drug sales, Actelion buy power J&J’s profit beat

(Reuters) – Johnson & Johnson reported a higher-than-expected quarterly profit and raised its full-year forecast, driven by strong demand for its new cancer drugs and gains from its acquisition of Swiss biotech Actelion.

Powered by WPeMatico